topiramate

What impact does maternal obesity have on fetal growth?Results of a study of fetal ultrasounds show that maternal obesity has an impact on fetal growth as early as 32 weeks’ gestation. Plus: Breast cancer risks increased by 21% in women who consumed more than 9 g of processed meat per day, according to a published study. Also: Does prenatal use of topiramate increase risk of cleft palate?
Diagnosing and managing patients with narrow angles
Diagnosing and managing patients with narrow anglesThe next patient sitting in your chair may have narrow angles. Find out how to best diagnose and manage patients with narrow angles; it can have a significant long-term impact on their visual outcome.
Antiepileptic drug can now be used in pediatric patientsFDA has expanded the indication for topiramate (Qudexy XR, Upsher-Smith Laboratories) extended-release capsules within the pediatric population.
Rising temperatures linked to increased stone riskIncreasing daily temperature appears to be associated with an increased risk of kidney stones, results of a recently published multicenter study suggest.
Study: Topiramate XR improves seizure control in epilepsy patientsAn extended-release formulation of topiramate (Qudexy XR, Upsher-Smith Laboratories) has been shown to be sale and effective in refractory epilepsy patients in a global phase 3 clinical trial.
FDA Drug Approvals: April 2014FDA actions in brief, fast-track designation, orphan drug designation, first-time generic approvals
FDA approves once-daily topiramate XR for refractory seizuresFDA has approved once-daily topiramate extended-release capsules for initial monotherapy to treat partial-onset or primary generalized tonic-clonic seizures.